SCHEMBL9811056

SCHEMBL9811056

Fc1ccc2c(c1)Cc1ccc(F)cc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 2/20 0.49
▸ CYP17A1 P05093 1/20 0.44
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ PARP1 P09874 3/20 0.41
▸ ACHE P22303 2/20 0.41
▸ PARP10 Q53GL7 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4896474 0.93 PARP1 (0.45) PGRCYP17A1CA1CA2CA4
SCHEMBL577480 0.93 PGR (0.49) PGRCYP17A1CA1CA2CA4
SCHEMBL17068947 0.86 ALDH1A1 (0.59) PGRCA1CA2CA4CA6
SCHEMBL5080927 0.86 ALDH1A1 (0.59) PGRCA1CA2CA4CA6
SCHEMBL29851576 0.86 ALDH1A1 (0.59) PGRCA1CA2CA4CA6
SCHEMBL6557452 0.86 ALDH1A1 (0.53) PGRCA1CA2CA4CA6
SCHEMBL24727259 0.86 METAP1 (0.44) PGRCYP17A1CA1CA2CA4
SCHEMBL9810960 0.86 LMNA (0.63) PGRCYP17A1CA1CA2CA4
SCHEMBL23166405 0.80 TDP2 (0.46) PGRCYP17A1CA1CA2CA4
SCHEMBL24727227 0.80 METAP1 (0.47) PGRCYP17A1CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0092385-B1 HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS ALCON LABORATORIES, INC. (US) 1991-06-12 — — EP disclosed
US-4540700-A Treatment of diabetic complications with certain spiro-imidazolidine-diones ALCON LABORATORIES, INC. (US) 1985-09-10 — — US disclosed
US-4438272-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1984-03-20 — — US disclosed
US-4436745-A TETRACYCLIC SPIROHYDANTOINS ALCON LABORATORIES, INC. (US) 1984-03-13 — — US disclosed
WO-1983003543-A1 METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS ALCON LAB INC (US) 1983-10-27 — — WO disclosed
EP-0092385-A2 Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds ALCON LABORATORIES, INC. (US) 1983-10-26 — — EP disclosed
Send feedback